GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Biote Corp (NAS:BTMD) » Definitions » Long-Term Debt

Biote (BTMD) Long-Term Debt : $105.3 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Biote Long-Term Debt?

Biote's Long-Term Debt for the quarter that ended in Mar. 2024 was $105.3 Mil.

Biote's quarterly Long-Term Debt declined from Sep. 2023 ($108.0 Mil) to Dec. 2023 ($106.6 Mil) and declined from Dec. 2023 ($106.6 Mil) to Mar. 2024 ($105.3 Mil).

Biote's annual Long-Term Debt increased from Dec. 2021 ($32.0 Mil) to Dec. 2022 ($112.1 Mil) but then declined from Dec. 2022 ($112.1 Mil) to Dec. 2023 ($106.6 Mil).


Biote Long-Term Debt Historical Data

The historical data trend for Biote's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biote Long-Term Debt Chart

Biote Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
- 36.74 31.96 112.09 106.63

Biote Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 110.72 109.35 107.99 106.63 105.27

Biote  (NAS:BTMD) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Biote Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Biote's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Biote (BTMD) Business Description

Traded in Other Exchanges
N/A
Address
1875 West Walnut Hill Lane, Suite 100, Irving, TX, USA, 75038
Biote Corp is engaged in bioidentical hormone replacement optimization platform and complementary nutraceutical business. The company offers end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support.
Executives
Mary Elizabeth Conlon officer: General Counsel C/O BIOTE CORP., 1875 W. WALNUT HILL LN #100, IRVING TX 75038
Anil K Shrivastava 10 percent owner 200 PARK AVENUE, 17TH FLOOR, NEW YORK NY 10016
Michael David Braner 10 percent owner 200 PARK AVENUE, 17TH FLOOR, NEW YORK NY 10016
Daniel M. Friedberg 10 percent owner C/O SAGARD CAPITAL, 325 GREENWICH AVENUE, GREENWICH CT 06830
325 Capital Llc 10 percent owner 757 THIRD AVENUE, 20TH FLOOR, NEW YORK NY 10017
Mary Joan Puncochar officer: Chief Commercial Officer C/O BIOTE CORP., 1875 W. WALNUT HILL LN #100, IRVING TX 75038
Roystone Capital Holdings Llc 10 percent owner 767 THIRD AVENUE, 29TH FLOOR, NEW YORK NY 10017
Roystone Capital Management Lp 10 percent owner 780 THIRD AVENUE, 41ST FLOOR, NEW YORK NY 10017
Samar Jagat Kamdar officer: Chief Financial Officer 7042 CORONADO AVE., DALLAS TX 75214
Marc D Beer director C/O AEGERION PHARMACEUTICALS, 89 HEADQUARTERS PLAZA, SUITE 1212, MORRISTOWN NJ 07960
Guines Llc 10 percent owner 767 THIRD AVENUE, 29TH FLOOR, NEW YORK NY 10017
Richard R Barrera 10 percent owner 767 THIRD AVENUE, 29TH FLOOR, NEW YORK NY 10017
Debra L Morris director 11620 WILSHIRE BOULEVARD, SUITE 1000, LOS ANGELES CA 90025
Andrew R Heyer director, officer: President and Director 501 MADISON AVENUE, FLOOR 5, NEW YORK NY 10019
Teresa Sue Weber director, officer: Chief Executive Officer C/O BIOTE CORP., 1875 W. WALNUT HILL LN #100, IRVING TX 75038

Biote (BTMD) Headlines

From GuruFocus

Biote to Present at 35th Annual Roth Conference

By Business Wire Business Wire 03-02-2023

Biote Appoints Debby Morris to Board of Directors

By Business Wire Business Wire 11-07-2022

Biote Appoints Ross W. McQuivey, M.D. as Chief Medical Officer

By Business Wire Business Wire 06-16-2022

Biote to Purchase Asteria Health

By Business Wire 01-17-2024

Biote Announces Pricing of Secondary Offering of Common Stock

By Business Wire Business Wire 06-05-2023

Biote Announces Pricing of Secondary Offering of Common Stock

By Business Wire Business Wire 01-05-2023